<DOC>
	<DOCNO>NCT00078260</DOCNO>
	<brief_summary>The purpose study determine : - safety pemetrexed side effect might associate - much pemetrexed give patient . It possible information collect study analyze Sponsor future evaluate pemetrexed possible us medical scientific purpose currently propose . Although pemetrexed show effective patient non-small-cell lung cancer , pemetrexed might beneficial effect patient .</brief_summary>
	<brief_title>A Comparison Two Doses Pemetrexed Patients Who Have Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Diagnosis locally advance metastatic ( Stage III IV entry ) nonsmall cell lung cancer ( NSCLC ) amenable curative therapy . Patients must previously treat one platinumcontaining chemotherapy regimen locally advance metastatic disease . Patients also eligible receive one platinumbased chemotherapy regimen neoadjuvant adjuvant chemotherapy , must receive additional chemotherapy regimen upon recurrence . No two prior systemic anticancer therapy allow . Prior radiation therapy allow less 25 % bone marrow . Prior radiation whole pelvis allow . Prior radiotherapy must complete least 2 week study enrollment , patient must recover acute toxic effect treatment prior study enrollment . Pregnancy . Breastfeeding . Second primary malignancy clinically detectable time consideration study enrollment . Inability interrupt aspirin , nonsteroidal antiinflammatory agent 5day period . Inability unwillingness take folic acid vitamin B12 supplementation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>